INR Advisory Services’s ResMed RMD Stock Holding History

INR Advisory Services’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-40	Closed	-$3K	–	83
2017 Q2	$3K	Buy	+40	New	+$2.86K	﹤0.01%	82

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

CBOA

Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

INR Advisory Services's RMD Position: Q3 2017 in Review

INR Advisory Services sold out of ResMed (RMD) in Q3 2017, closing a stake of 40 shares — an estimated $3K sold.

INR Advisory Services first reported a position in RMD in Q2 2017 and held it in 1 quarter. The position peaked at $3K in Q2 2017. 362 funds tracked by Wall St. Rank hold RMD as of Q3 2017.

INR Advisory Services reported no remaining ResMed position as of Q3 2017 after selling out during the quarter.
INR Advisory Services sold 40 ResMed shares in Q3 2017, an estimated $3K.
INR Advisory Services first reported a position in ResMed in Q2 2017 and held it in 1 quarter.
INR Advisory Services's ResMed position peaked at $3K in Q2 2017.
362 funds tracked by Wall St. Rank held ResMed as of Q3 2017.

Based on INR Advisory Services's 13F filing for Q3 2017, filed 9 Nov 2017.